MYMMF - MYM Nutraceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.38
-0.05 (-3.46%)
As of 11:13AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.43
Open1.43
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.33 - 1.45
52 Week Range0.13 - 4.00
Volume150,941
Avg. Volume306,916
Market Cap150.402M
Beta7.76
PE Ratio (TTM)N/A
EPS (TTM)-0.02
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire6 days ago

    MYM Announces Launch of Canadian Awareness Campaign

    MYM Nutraceuticals Inc., (MYMMF) (MYM.CN) (MYM.CN) (MYM.CN) (the "Company" or "MYM") is pleased to announce the launch of its Cannabis Awareness Campaign - "It all unfolds this summer", focusing on topics surrounding the impending legalization of recreational cannabis. The website will aim to create a dialogue on the impending legalization of recreational cannabis slated to occur this summer. The website will encourage users to participate in a nationwide discussion on issues surrounding the legalization of recreational cannabis that matter to them.

  • CNW Group6 days ago

    MYM Announces Launch of Canadian Awareness Campaign

    MYM Announces Launch of Canadian Awareness Campaign

  • With A -122.54% Earnings Drop, Did MYM Nutraceuticals Inc (FRA:0MY) Really Underperform?
    Simply Wall St.last month

    With A -122.54% Earnings Drop, Did MYM Nutraceuticals Inc (FRA:0MY) Really Underperform?

    Today I will examine MYM Nutraceuticals Inc’s (DB:0MY) latest earnings update (30 November 2017) and compare these figures against its performance over the past couple of years, in addition toRead More...

  • CNW Group2 months ago

    MYM Appoints New Chief Science Officer

    MYM Appoints New Chief Science Officer

  • PR Newswire2 months ago

    MYM Appoints New Chief Science Officer

    VANCOUVER, British Columbia , March 7, 2018 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (MYM.CN) (the "Company" or "MYM") is pleased to announce Dr. Charith Adkar ...

  • CNW Group2 months ago

    MYM Receives Permit Approval to Begin Construction on Phase One of Weedon, Quebec Project

    MYM Receives Permit Approval to Begin Construction on Phase One of Weedon, Quebec Project

  • PR Newswire2 months ago

    MYM Receives Permit Approval to Begin Construction on Phase One of Weedon, Quebec Project

    MYM Nutraceuticals Inc., (CSE:MYM) (MYM.CN) (MYM.CN) (the "Company" or "MYM") is pleased to announce the Municipality of Weedon, QC has approved the building permit to begin construction on the 1.5 million sqft greenhouse at the Weedon QC production facility. MYM has received approval and commenced Phase One construction of the Weedon production facility. Phase One of the Weedon project will consist of building 300,000 sqft of greenhouse space for growing medical cannabis and 20,000 sqft for processing and manufacturing medical cannabis products.

  • CNW Group2 months ago

    MYM Appoints New Chief Financial Officer

    MYM Appoints New Chief Financial Officer

  • PR Newswire2 months ago

    MYM Appoints New Chief Financial Officer

    MYM Nutraceuticals Inc., (MYM.CN) (MYM.CN) (MYMMF) (the "Company" or "MYM") is pleased to announce Craig Lennox has joined MYM as its new Chief Financial Officer (CFO) effective February 26, 2018. Lennox joins MYM from Clearly, a leading online optical retailer, where he was most recently Chief Financial Officer. Lennox is Chartered Professional Accountant (CA) and brings with him an extensive background in public accounting and broad experience in financial management.

  • CNW Group2 months ago

    MYM Announces Closing of Non-Brokered Financing

    MYM Announces Closing of Non-Brokered Financing

  • PR Newswire2 months ago

    MYM Announces Closing of Non-Brokered Financing

    MYM Nutraceuticals Inc., (CSE:MYM) (MYMMF) (the "Company" or "MYM") is pleased to announce it has closed its non-brokered private placement of 535,319 units at a price of $2.25 per unit for gross proceeds of $1,204,467.75 (the "Private Placement"). Insiders subscribed to 100,443 units for gross proceeds of $225,996.75.  As a result, the Private Placement is considered to be a "related party transaction" as defined under Multilateral Instrument 61-101 ("MI 61-101"). The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of any shares issued to or the consideration paid by such persons exceeded 25% of the Company's market capitalization.

  • PR Newswire2 months ago

    MYM Nutraceuticals Completes Purchase of Budly Cannabis Home Delivery App Software and Assets

    VANCOUVER, British Columbia , February 26, 2018 /PRNewswire/ -- MYM Nutraceuticals Inc. (CSE:MYM) (CSE:MYM.CN) (OTC:MYMMF) ("MYM") ("MYM.CN") is pleased to announce that the Company ...

  • PR Newswire2 months ago

    MYM Nutraceuticals Completes Purchase of Budly Cannabis Home Delivery App Software and Assets

    VANCOUVER, British Columbia , February 26, 2018 /PRNewswire/ -- MYM Nutraceuticals Inc. (CSE:MYM) (CSE:MYM.CN) (OTC:MYMMF) ("MYM") ("MYM.CN") is pleased to announce that the Company ...

  • PR Newswire2 months ago

    MYM Announces Closing of $10,000,000 Non-Brokered Financing and Additional Financing of up to $2,000,000.

    MYM Nutraceuticals Inc., (CSE:MYM) (MYMMF) (MYM.CN) (MYM.CN) ("MYM") is pleased to announce it has closed its non-brokered private placement of 5,000,000 units at a price of $2.00 per unit for gross proceeds of $10,000,000. Each unit in the private placement is comprised of one common share and one transferable share purchase warrant with each warrant exercisable into one additional common share at a price of $3.00 for a period of two years.

  • CNW Group2 months ago

    MYM Announces Closing of $10,000,000 Non-Brokered Financing and Additional Financing of Up to $2,000,000

    MYM Announces Closing of $10,000,000 Non-Brokered Financing and Additional Financing of Up to $2,000,000

  • PR Newswire2 months ago

    MYM Announces Closing of $10,000,000 Non-Brokered Financing and Additional Financing of up to $2,000,000.

    MYM Nutraceuticals Inc., (CSE:MYM) (MYMMF) (MYM.CN) (MYM.CN) ("MYM") is pleased to announce it has closed its non-brokered private placement of 5,000,000 units at a price of $2.00 per unit for gross proceeds of $10,000,000. Each unit in the private placement is comprised of one common share and one transferable share purchase warrant with each warrant exercisable into one additional common share at a price of $3.00 for a period of two years.

  • CNW Group2 months ago

    Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture

    Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture

  • PR Newswire2 months ago

    Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture

    MYM Nutraceuticals Inc., (MYM.CN) (MYM.CN) (MYMMF) ("MYM") is pleased to announce a joint venture agreement between Southern Cross University and Solaris Nutraceuticals to commit to the development of hemp and medicinal cannabis products in the NSW Northern Rivers region that will enhance animal and human health. Vice-Chancellor Professor Adam Shoemaker said the agreement was a great step forward not just for the region, but also for consumers. "Universities have a vital role to play as catalysts for diversification and development - creating new opportunities through 21st century industries," said Professor Shoemaker.

  • CNW Group2 months ago

    Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science

    Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science

  • PR Newswire2 months ago

    Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science

    MYM Nutraceuticals Inc., (MYM.CN) (MYM.CN) in response to an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant and its strategic partners PUF Ventures Inc. (CSE:PUF) are pleased to announce the Australia based Solaris Nutraceuticals Pty Ltd, which is building the largest medical cannabis greenhouse southern hemisphere, has been awarded a $AUD2,500,000 Regional Jobs Investment Program (RJIP) grant, through Federal Department of Innovation, Industry & Science. "We are co-investing with Solaris Nutraceuticals to make sure it (the medicinal cannabis facility) happens," said Kevin Hogan, Australian Member of Parliament.

  • PR Newswire3 months ago

    Deloitte's Study of MYM's Weedon, Québec Project Shows Economic Benefit

    MYM Nutraceuticals Inc., (CSE:MYM) (MYMMF) (the "Company" or "MYM") is pleased to announce the completion of the "Economic Impact Assessment for the Weedon Project" from Deloitte, the world's leading accounting experts. "The Economic Impact Study produced by Deloitte provides valuable insight into the immense benefits that the Weedon Project could have on the Province of Québec and Canada as a whole," said Rob Gietl, CEO of MYM.

  • CNW Group3 months ago

    Deloitte's Study of MYM's Weedon, Québec Project Shows Economic Benefit

    Deloitte's Study of MYM's Weedon, Québec Project Shows Economic Benefit

  • PR Newswire3 months ago

    MYM Responds to Recent News out of the United States and Provides Global Operations Update

    In response to recent news out of the United States Department of Justice regarding federal cannabis laws in the United States, MYM Nutraceuticals Inc., (CSE:MYM) (MYMMF) ("MYM") wishes to reinforce its commitment to growing and conducting business only in jurisdictions where that conduct is federally legal and otherwise in full compliance with all applicable laws in place. MYM does not currently have any operations in the United States and will not engage in that country unless significant changes to the federal laws regarding cannabis are made. MYM Nutraceuticals is an international company, with operations in Australia, Canada, and most recently seeking operations in Colombia.

  • CNW Group3 months ago

    MYM Responds to Recent News out of the United States and Provides Global Operations Update

    MYM Responds to Recent News out of the United States and Provides Global Operations Update

  • CNW Group3 months ago

    MYM Signs MoU With Colombian Medical Cannabis Company NEWCANNA

    MYM Signs MoU With Colombian Medical Cannabis Company NEWCANNA